How is Alpha 1-antitrypsin deficiency diagnosed?

Alpha 1-antitrypsin deficiency is diagnosed primarily through a combination of blood tests measuring the AAT protein level and definitive genetic testing to identify specific mutations in the SERPINA1 gene. Because symptoms often mirror more common respiratory or liver conditions, diagnosis requires a high index of clinical suspicion and specialized testing to confirm the deficiency.

How is Alpha 1-antitrypsin deficiency officially diagnosed?

The diagnostic pathway for Alpha 1-antitrypsin deficiency typically begins when a physician suspects the condition due to early-onset emphysema, unexplained liver disease, or a family history of the disorder. The process generally follows these clinical steps:

• Quantitative Blood Test: Measuring the serum concentration of the alpha-1 antitrypsin protein. Levels below 11 micromolar (or roughly 50-80 mg/dL, depending on the assay) are highly suggestive of Alpha 1-antitrypsin deficiency.


• Phenotyping/Genotyping: Once low levels are confirmed, genetic testing is required to identify the specific genotype (e.g., PiZZ, PiSZ). This is the gold standard for diagnosis.


• Liver Function Tests and Imaging: For those with liver involvement, ultrasound or transient elastography may be used to assess fibrosis or cirrhosis, which can sometimes be the first indicator of Alpha 1-antitrypsin deficiency.

Why is there often a long "diagnostic odyssey"?

Many patients in the DiseaseMaps.org community—which currently includes 339 individuals living with this condition—report a frustrating "diagnostic odyssey." Because Alpha 1-antitrypsin deficiency is frequently misdiagnosed as common asthma, chronic obstructive pulmonary disease (COPD), or idiopathic liver disease, it can take years to receive an accurate diagnosis. This delay often stems from a lack of awareness among primary care providers who may not consider a genetic cause for respiratory or liver symptoms in non-smokers or younger patients.

Which specialists are involved in the diagnosis?

Because Alpha 1-antitrypsin deficiency is a systemic condition, it requires a multidisciplinary approach. You will likely work with a pulmonologist for lung-related symptoms, a hepatologist for liver concerns, and a clinical geneticist or genetic counselor to understand the inheritance patterns and the implications for your family members. If you suspect you have this condition, it is vital to advocate for yourself; if your current doctor is unfamiliar with the deficiency, request a referral to a specialist at an academic medical center or a center of excellence for rare lung or liver diseases.

What are the common differential diagnoses?

Clinicians must distinguish Alpha 1-antitrypsin deficiency from other conditions that present with similar clinical features. For respiratory symptoms, it is often confused with standard COPD, asthma, or bronchiectasis. For the hepatic form of Alpha 1-antitrypsin deficiency, clinicians must rule out viral hepatitis, autoimmune liver disease, and non-alcoholic fatty liver disease (NAFLD). Accurate diagnosis is essential because the management of these conditions differs significantly from the specific therapeutic needs of AAT-deficient patients.

Next steps

• Consult with a pulmonologist or hepatologist specifically experienced in Alpha 1-antitrypsin deficiency.


• Request genetic counseling to understand your specific genotype and the impact on your family members.


• Connect with the 339 members on DiseaseMaps.org to share experiences and find support in your diagnostic journey.


• Keep a detailed log of your symptoms and test results to provide a clear history for your specialists.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Alpha-1 Antitrypsin Deficiency.


• Orphanet: Alpha-1 Antitrypsin Deficiency (ORPHA:60).


• OMIM (Online Mendelian Inheritance in Man): SERPINA1 gene information.


• Alpha-1 Foundation: Clinical guidelines and patient support resources.